Z3 Capital Partners, LLC

Position in ATAI — AtaiBeckley Inc.

CIK 2127787 RICHMOND, VA

Position in ATAI

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$487,606

New position

Shares Held

92,525

first reported quarter

Ownership

0.025%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#81

of 237 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Z3 Capital Partners, LLC holds $2,076,262 across 4 Biotechnology names. ATAI ranks #2 (23.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TRVI	Trevi Therapeutics, Inc.	39,250	$732,012
2	ATAI	AtaiBeckley Inc. This page	92,525	$487,606
3	CRSP	CRISPR Therapeutics AG	8,000	$436,320
4	DYN	Dyne Therapeutics, Inc.	18,925	$420,324

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$487,606	92,525	—	Shares	Sole	2026-07-28
No filing history on record for this holder in this stock.